ABSTRACT. The aim of this study was to compare the proteomics pattern of the kidneys from Cyld knockout mice with that from normal mouse kidneys and establish a preliminary understanding of the role of Cyld in the kidney. Proteins from the kidneys of knockout Cyld mice and wild-type mice were extracted, isobaric tags for relative and absolute quantitation (iTRAQ) was performed, and the proteomics patterns of the two groups were compared. The genotypes of the mice were verified by polymerase chain reaction. A total of 1748 proteins with a local false discovery rate of ≤5% were identified, among which 1437 proteins were reliably recognized and quantified. The expression of two dysregulated proteins was confirmed by Western blotting. Gene ontology and pathway analyses indicated that the proteins identified were involved in biological processes, cell components, and molecular functions, and participated in different pathways. Some of the proteins identified were relevant to renal function or kidney diseases. The difference between the proteomics profiles of kidneys from Cyld knockout mice and wild-type mice was prominent, which correlates to kidney dysfunction and the development of renal diseases.
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INTRODUCTION
As an important system for protein degradation, the ubiquitin proteasome system (UPS) regulates numerous cellular biochemical processes via the ubiquitination of substrate proteins and the participation of the proteasome (Demartino and Gillette 2007; Mukhopadhyay and Riezman, 2007; Schulman and Harper, 2009 ). The UPS is a precisely regulated system in which deubiquitinating enzymes play a significant role.
CYLD was first identified as a suppressor gene of human familial cylindromatosis. The CYLD protein was later classified as a deubiquitinating enzyme, and is involved in multiple signal pathways (Massoumi, 2010) . CYLD negatively regulates the NF-κB pathway, which plays a pathogenic role in mediating chronic inflammation in chronic kidney disease (CKD) (Rangan et al., 2009 ). The NF-κB pathway is consistently activated throughout the entire disease progression of anti-glomerular basement membrane (anti-GBM) glomerulonephritis, inducing various target genes, including complement 3 (C3), IL-1b, IL-6, TRAF1, and SAA1. Moreover, George et al. (2012) recently discovered the role of NF-κB-p65 in antioxidant and redox homeostasis in renal cells by demonstrating that NF-κB-p65 increases the expression of antioxidant enzymes (GPx1, SOD-1). Cui et al. (2009) found that CYLD plays a protective role in tubulointerstitial inflammation caused by IgA nephropathy, and Sun et al. (2009) reported similar results. A case reported by Ströbel et al. (2002) suggests that a mutation of CYLD is closely associated with the pathogenesis of spiradenocylindroma.
Proteomics combined with mass spectrometry (MS) has become a powerful paradigm for examining biological processes in a generalized manner by revealing unknown biological functions (Sui et al., 2008; Jin et al., 2009 ). In particular, isobaric tags for relative and absolute quantification (iTRAQ) labeling followed by multidimensional liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) analysis facilitates the detection of proteins in complex mixtures (Ross et al., 2004) . To determine the specific effect of CYLD on the kidney and its mechanism of action, we performed proteomic analysis on kidney samples from Cyld knockout mice.
MATERIAL AND METHODS

Cyld knockout mouse model
The generation and verification of Cyld knockout mice has been described previously (Zhang et al., 2006) . A section of the tail of each mouse was collected for polymerase chain reaction verification.
Protein extraction and quantification
Proteins were extracted from the kidneys of Cyld knockout and wild-type (WT) mice (N = 6 per group). The kidneys in each group were pooled and homogenized in ice-cold phosphate-buffered saline containing a protease inhibitor cocktail (Roche Complete Mini Tablets, Roche Applied Sciences; Indianapolis, IN, USA). The supernatant contained the extracted proteins. The concentrations of the protein extracts were determined using the Bradford method (Bradford, 1976) . The protein samples were stored at -80°C for isoelectric focusing or iTRAQ analysis.
iTRAQ labeling
The iTRAQ labeling technique was used to compare the protein expression profiles of kidneys from Cyld knockout and WT mice. iTRAQ labeling enabled the comprehensive analysis of differential proteome expression, as described previously (Jin et al., 2009 (Jin et al., , 2011 . For iTRAQ LC-MS/MS analysis, 50 µg clarified supernatants was denatured for 1 h at 60°C, the disulfide bonds were reduced, and the cysteine residues were blocked, as described in the iTRAQ protocol (Applied Biosystems, Foster City, CA, USA). The two groups of kidneys, Cyld knockout and WT, were labeled using iTRAQ reagents 119 and 121, respectively.
Strong cation exchange chromatography
The dried sample was resuspended in 100 µL buffer A (10 mM H 3 PO 4 /KH 2 PO 4 in an aqueous solution of 25% acetonitrile and acidified to a pH of 3.0 using phosphoric acid). Each sample was then separated via off-line strong cation exchange chromatography using the Agilent 1200 HPLC system (Agilent, Palo Alto, CA, USA). The first fraction from 1-5 min was collected, and then each fraction was collected for 3-min intervals from 5-35 min; the final fraction from 35-46 min was collected, making a total of 12 fractions. All fractions were dried in a vacuum-freezing dryer for LC-MS/MS analysis.
Reverse-phase LC-MS/MS analysis
The samples were resuspended in re-dissolving solution, loaded on a C18RP precolumn (100 μm x 3 cm, C18, 3 μm, 150 Å), and desalted for 10 min using the Eksigent nanoLC-Ultra™ 2D System (Eksigent Technologies, USA). Separation was performed using an elution gradient from 5 to 35% beginning with Eluant A (consisting of 94.9% deionized water, 5.0% methanol, and 0.1% formic acid, pH = 3) and transitioning to Eluant B (5.0% deionized water, 94.9% methanol, and 0.1% formic acid) over 70 min. The LC-MS/MS analysis was performed using a TripleTOF 5600 System (Applied Biosystems/ MDSSIEX), and the MS data were acquired in information-dependent acquisition mode. The data were processed using the mouse database of the Protein Pilot Software version 4.0 (AB SCIEX). The tolerances were specified as ±0.05 Da for peptides and ±0.05 Da for MS/ MS fragments. False discovery rate (FDR) analysis was also performed using the internal tools of ProteinPilot. Only the proteins identified with a local FDR ≤ 5% were considered for further analysis.
Bioinformatic analysis
To improve the confidence of protein quantification, the iTRAQ expression ratios of the proteins were based on the criterion that the protein must be identified by a minimum of two peptides with ≥95% confidence. Proteins were considered to be differentially expressed if the iTRAQ ratios were ≥1.5 or ≤0.67 in the kidneys of the Cyld knockout mice relative to the WT mice. Gene Ontology (GO) analysis was performed using the DAVID toolkit. Public resources, such as NCBI (The National Center for Biotechnology Information), PIR (Protein Information Resource), and GO, were used to integrate the protein ID and the corresponding gene ontology information. The proteins were classified into groups according to biological process (BP), molecular function (MF), and cell component (CC). Pathway enrichment was performed by comparing the annotated enzymes in the query dataset to the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Interactions between the query proteins were collected from the string database.
Western blot analysis
Dysregulated protein expression in Cyld knockout kidney samples was verified by Western blot analysis as described before (Masui et al., 2013) . The proteins used (and their antibodies) were: Hsd17b4 (Abcam ab170910) and AKR1B3 (ABcam ab175394).
RESULTS
Verification of the Cyld knockout model
The genotypes of mice from groups 119 and 121 were verified to be Cyld knockout and WT, respectively ( Figure S1 ).
Identification and validation of differentially expressed proteins
We identified 1748 proteins with a local FDR ≤ 5%, among which 1437 proteins were reliably recognized and quantified (at least 2 peptides were identified) ( Table S1 ). By measuring the ratio of 119:121, we determined that 20 proteins were upregulated and 20 proteins were downregulated in the Cyld knockout kidneys (Table 1) . A large proportion of the proteins are relevant to renal function or kidney disease.
Validation of dysregulated protein expression
To validate our MS analysis, we confirmed the differential expressions of two dysregulated proteins by Western blot analysis using samples from the Cyld knockout and WT groups. The peroxisomal multifunctional enzyme (Hsd17b4) and aldose reductase (AKR1B3) were selected for validation based on their interesting biology and potential significance in kidney tumors (Figure 1 ). 
GO analysis
We subjected the 40 differentially expressed proteins in Cyld knockout mice to GO analysis and three categorizations were performed: BP, CC, and MF. Based on the analyses, 36 (92.3%), 34 (87.2%), and 37 (94.9%) proteins were classified according to BP, CC, and MF, respectively.
For BP, 45 biological processes were enriched, 34 of which displayed a P value <0.05. The top 10 enriched processes are presented here (Figure 2A) , all of which are involved in the energy metabolism process. For CC, 13 different cellular components were enriched, 10 of which displayed a P value <0.05. The top 10 components are presented here ( Figure 2B ), which are located in the mitochondria and the sarcomeres. For MF, 14 different groups were enriched, 9 of which displayed a P value <0.05, which are presented in Figure 2C . These processes included coenzyme binding and cellular metabolism. 
Pathway analysis
Pathway enrichment was performed by comparing the annotated enzymes in the query dataset to the KEGG database. Twenty-five proteins in total were mapped into 10 pathways, 7 of which displayed a P value <0.05. All of the enriched pathways containing more than 2 query proteins mapped are presented in Figure 3 . The primary related pathways were amino acid metabolism, the complement and coagulation cascades, and the peroxisome proliferatoractivated receptors (PPAR) signaling pathway. 
DISCUSSION
Kidney diseases are life-threatening, non-communicable diseases that diminish a patient's quality of life. CKD is the general outcome of most types of kidney disease and has now become one of the most common causes of death. It is estimated that more than 10% or 20 million of individuals aged 20 years or older in the United States suffer from CKD and require dialysis treatment or a kidney transplant [data from the Centers for Disease Control and Prevention (CDC), USA].
To our knowledge, our study is the first to profile the proteome of kidneys from Cyld knockout mice using the iTRAQ technique. A total of 1437 proteins in total were reliably identified, which constituted a database of proteins for the Cyld knockout model. Among the dysregulated proteins, a large proportion are relevant to renal function or kidney disease.
AKR1B3, which is downregulated in adrenal tumors (Lefrançois-Martinez et al., 2004) , is downregulated after Cyld knockout (fold change: 0.12), indicating that deletion of Cyld may increase the risk of adrenal tumor formation. It is also reported that the polymorphism of AKR1B1 (the human equivalent of AKR1B3) is closely associated with diabetic autonomic neuropathy (Donaghue et al., 2005) , which suggests that AKR1B1 could be used as an early biomarker of autonomic neuropathy. Another report revealed that homozygotes of the aldose reductase z-2 allele exhibited elevated plasma creatinine levels and an increased risk of classic diabetic glomerulopathy (Zhao et al., 2004) , and we propose that the deletion of Cyld might help to reduce the risk of classic diabetic glomerulopathy. The expression of Hsd17b4, the peroxisomal multifunctional enzyme type 2, is increased in esophageal cancer and prostate cancer (Li et al., 2005; Rasiah et al., 2009) . It is also a biomarker of breast cancer (Flanagan et al., 2009) . Considering the similarity between renal tumors and the cancers mentioned above, we predicted that Hsd17b4 is also upregulated in renal tumors. However, based on our results, Hsd17b4 is downregulated in the case of Cyld knockout mice (fold change: 0.45), implying that Cyld is a risk factor of renal tumor formation.
As shown in Figure 3 , 10.3% of the dysregulated proteins are involved in the PPAR pathway. It has been well demonstrated that the PPARγ pathway is crucial for maintaining renal function, and PPAR agonists have been widely utilized to treat CKD, progressive kidney disease, and diabetes Fogo, 2011; Boor, 2012) . On the other hand, PPARγ inhibits the expression of NF-κB induced by high glucose levels , which suggests that to some extent, both Cyld and PPARγ prevent the pathological progression from high glucose levels to diabetes. It is also possible that the PPARγ pathway is positively regulated by Cyld based on their equivalent ability to inhibit the expression of NF-κB.
The complement and coagulation cascades are also important pathways in which 10.3% of the dysregulated proteins participate. Many components of these pathways are involved in the inflammation response and the loss of renal function . Several proteins in these pathways are upregulated; for example, PLG, KNG, FG, and C3 have foldchanges in expression of 5.81, 3.16, 2.25, and 3.34, respectively. These results imply that deletion of Cyld may enhance the inflammatory response. Therefore, Cyld may perform an anti-inflammatory role in renal tissue.
It is important to note that this experiment is predominantly based on proteomic analysis of the kidneys from Cyld knockout mice and should be regarded as an estimation of the proteomic profile, which provides potential biomarkers of kidney diseases. To further explore the function of individual proteins, renal function should be evaluated, and ultrasound should be performed to detect any morphological changes in the kidney.
